In the CD8+ T cell enrichment model, patients with high WDHD1 expression had a poor prognosis, while in patients not enriched with CD8+ T cells, WDHD1 expression had no significant effect on the survival of BLCA patients. This evidence concerns the gene WDHD1 and bladder transitional cell carcinoma.